Amid a shortage of Remdesivir, the Supreme Court on April 30 asked whether the Centre has considered invoking section 92 of the Patents Act to boost the availability of COVID-19 medicines.
While hearing a suo-motu case on India's COVID-19 crisis, three-judge Bench of Justices DY Chandrachud, L Nageswara Rao and Ravindra Bhat questioned if the government plans to issue compulsory licences so that drugs can be manufactured while royalties are sorted.
Bangladesh has developed a generic drug for Remdesivir and is exporting the same to other countries, it noted.
The apex court also suggested that India can obtain a licence from Bangladesh to produce a generic version of the drug locally.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
"Compulsory licences can be granted with a sunset clause which shows that such licences will be over once the pandemic is over. Doha Declaration of TRIPS show that member states can take such steps to protect the right of public health," Justice Chandrachud said, reported Bar & Bench.It further asked why the bench should not issue directions under Section 100 and Section 92 of the Patents Act to enable generics to manufacture COVID-19 medicine without the fear of legal action to overcome the shortage.
Justice Chandrachud: Compulsory licenses can be granted with sunset clause which shows that such licenses will be over once the pandemic is over. Doha Declaration of TRIPS show that member states can take such steps to protect right of public health
— Bar & Bench (@barandbench) April 30, 2021
The court also said that there should be no clampdown on citizens seeking help on the presumption that they are raising false grievances on the internet.
"There should be free flow of information, we should hear voices of citizens," said SC, and asked the Centre, states and all DGPs not to take any action against anyone posting a shortage of oxygen, beds or doctors as spreading a rumour.Track this LIVE blog for latest updates on coronavirus pandemic